Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze
05:03pm, Monday, 27'th Mar 2023
Short squeeze stocks are the talk of Wall Street at the moment. As the banking crisis continues to unfold, some investors are seeking refuge by betting against many well-known losers — and reaping t
3 Stocks That Won't Survive a Major Market Crash
09:30pm, Thursday, 23'rd Mar 2023
We've already seen valuations drop in 2022, as investors priced in an economic slowdown. However, it's unclear whether a full-on market crash is being priced into equity markets right now.
Why Novavax Stock Slipped on Thursday
05:23pm, Thursday, 23'rd Mar 2023
The company now has a vacancy at the top of its research and development department. Greg Glenn will officially vacate his post on March 31.
1 Green Flag and 1 Red Flag for Novavax
05:30am, Saturday, 18'th Mar 2023
Novavax missed out on the first big wave of vaccine demand -- and that's weighed on the company's progress. Now, the biotech is taking steps to improve its chances of success in a post-pandemic world.
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
09:44pm, Tuesday, 14'th Mar 2023
During the Covid-19 pandemic, vaccine stocks shot up on the promise that they could end the lockdowns. Many vaccines were developed, but few were approved.
This Growth Stock Is Down 90%. Is It Time to Sell or Buy?
08:45am, Sunday, 12'th Mar 2023
Novavax's COVID-19 vaccine hasn't made it profitable. The business is now struggling to stay afloat.
1 Stock You Need to Sell Before the Next Bull Market
09:45am, Saturday, 11'th Mar 2023
Novavax isn't going to rally if there's a bull market, as it has severe problems. It expects to cut costs, and its leaders think it could realistically close down.
Novavax Stock: Bear vs. Bull
02:00pm, Friday, 10'th Mar 2023
Novavax is facing declining vaccine demand and higher costs. At the same time, the company is working on a combined flu/coronavirus vaccine candidate that could stand out in a post-pandemic market.
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
10:00am, Wednesday, 08'th Mar 2023
Novavax reported an unprofitable 2022 despite strong revenue from its COVID-19 vaccine. The company's rate of cash burn has been sustainable, but that could change this year.
Why Is Novavax (NVAX) Stock Up 12% Today?
03:09pm, Friday, 03'rd Mar 2023
While the major equity indices finally printed a solid performance to close out a rough week, biotechnology firm Novavax (NASDAQ: NVAX ) raised eyebrows of its own. After mounting pressure from bearis
Should You Give Up on Novavax?
02:00pm, Friday, 03'rd Mar 2023
After a spectacular 2020 performance, Novavax's shares have plummeted.
Why Novavax Stock Was Down in the Dumps This Week
10:54am, Friday, 03'rd Mar 2023
Investors were disappointed yet again with the vaccine company's quarterly earnings and forward guidance.
Novavax stock continues plunge following disclosure of serious financial challenges
04:21pm, Wednesday, 01'st Mar 2023
The Yahoo Finance Live's Dave Briggs, Seana Smith, and Josh Schafer discuss the sharp drop in Novavax stock on Wednesday.
5 Investors Still Betting Big on Novavax (NVAX) Stock
03:14pm, Wednesday, 01'st Mar 2023
Novavax (NASDAQ: NVAX ) stock is down more than 25% today after the biotechnology company reported fourth-quarter earnings and raised doubts about its ability to continue as a “going concern.” The
Novavax stock falls sharply amid significant uncertainty
02:43pm, Wednesday, 01'st Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Novavax shares falling following quarterly earnings, plus news that Eli Lilly plans to reduce the cost of its insulin price by 70%.
